Influence of cyclooxygenase inhibitors on the central histaminergic stimulation of hypothalamic-pituitary-adrenal axis

Journal of Physiology and Pharmacology

Volumn 54, Issue 4, 2003, Pages 643-652

  Bugajski, A J ^a   Thor, P ^a   Glod R ^b   Gadek Michalska A ^b   Bugajski, J ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

ACTH; Amthamine; Corticosterone; COX 1; COX 2; Histamine; HTMT; Prostaglandins

Indexed keywords

AMTHAMINE; CORTICOSTERONE; CORTICOTROPIN; HISTAMINE; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE TRIFLUOROMETHYLTOLUIDINE DERIVATIVE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NEUROTRANSMITTER; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; HORMONAL REGULATION; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; RAT; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; HISTAMINE; HISTAMINE AGONISTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDOMETHACIN; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; ISOENZYMES; MALE; MEMBRANE PROTEINS; NITROBENZENES; PIROXICAM; PITUITARY-ADRENAL SYSTEM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; SULFONAMIDES; THIAZOLES;

EID: 0346102698     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Panula P, Pirvola U, Auvienin, Airaksinen MS. Histamine-immunoreactive nerve fibres in the rat brain. Neuroscience 1989; 28: 585-610.
2. Haas HL, Brown RE, Deller T, Eriksson KS, Sergeeva OA, Stevens DR. Physiology and pharmacology of histaminergic neurons. Histamine Research in the New Millenium ed by T. Watanabe, H. Timmerman, K. Yandi. Elsevier Exccrpta Medica ICS 2001; 1224: 39-44.
3. Brown RE, Stevens DR, Hass HL. The physiology of brain histamine. Prog Neurobiol 2001; 63: 637-672.
4. Arrang J-M. Pharmacological properties of histamine receptor subtypes. Cell Mol Biol 1994; 40: 273-279.
5. Leurs R, Smit MJ, Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmac Ther 1995; 66: 413-463.
6. Van der Goot H, Timmerman H. Selective ligands as tools to study histamine receptors. Eur J Med Chem 2000; 35: 5-20.
7. 2 receptor in adult and developing rat brain. Neuroscience 2001; 102: 201-208.
8. Schaad NC, Magistretti PJ, Schorderet M. Prostanoids and their role in cell-cell interactions in the central nervous system. Neurochem Int 1991; 18: 303-322.
9. Anthonisen M, Knigge U, Kjoer A, Warberg J. Histamine and prostaglandin interaction in the central regulation of ACTH secretion. Neuroendocrinology 1997; 66: 68-74.
10. 2 in the rat. Prostaglandins, Leukotrienes and Essential Fatty, Acids 1997; 56: 165-168.
11. Bugajski J, Głod R, Ga̧dek-Michalska A, Bugajski AJ. Involvement of constitutive (COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced ACTH and corticosterone secretion. J Physiol Pharmacol 2001; 52: 795-809.
12. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2002; 53: 453-462.
13. Tsujimoto S, Okumura Y, Kamei C, Tasaka K. Effects of intracerebroventricular injection of histamine and releated compounds on corticosterone release in rats. Br J Pharmacol 1993; 109: 807-813.
14. Bugajski AJ, Koprowska B, Thor P, Głód R, Bugajski J. Involvement of nitric oxide in central histaminergic stimulation of the hypothalamic-pituitary-adrenal axis. J Physiol Pharmacol 2000; 51: 907-915.
15. Szeberenyi JB, Orso E, Laszlo V, Falus A, Schmitz G. Histamine and H2 agonist amthamine increase oxidative burst activity in human leukocytes determined by flow now cytometry. Inflamm Res. Suppl 2000; 49: S72-S73.
16. Bugajski J, Ģdek-Michalska A, Głód R, Bugajski AJ. Effect of social stress on COX-1 and COX-2-induced alterations in the adrenergic agonists-evoked hypothalamic-pituitary-adrenal responses. J Physiol Pharmacol 2001; 52: 811-822.
17. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Involvement of prostaglandins in the nicotine-induced pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2002; 53: 847-857.
18. Breder CD, Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 1995; 355: 296-315.
19. Amann R, Schuligoi R, Peskar BA. Effect of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung. Inflamm Res 2001; 50: 50-53.
20. 2-receptor mediating inhibition of arachidonate release and activation of cAMP accumulation. Proc Natl Acad Sci 1992; 89: 2649-2653.
21. Katori M, Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Rea 2000; 49: 367-392.